Guardian Life Insurance’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-420
Closed -$65K 381
2019
Q4
$65K Hold
420
0.02% 271
2019
Q3
$57K Buy
420
+7
+2% +$917 0.01% 290
2019
Q2
$50K Hold
413
0.01% 321
2019
Q1
$43K Buy
413
+11
+3% +$1.14K 0.01% 340
2018
Q4
$46K Hold
402
0.01% 289
2018
Q3
$46K Buy
402
+8
+2% +$876 0.01% 323
2018
Q2
$41K Buy
394
+68
+21% +$6.88K 0.01% 339
2018
Q1
$32K Sell
326
-134
-29% -$12.7K 0.01% 360
2017
Q4
$39K Buy
460
+138
+43% +$11.4K 0.01% 402
2017
Q3
$25K Buy
+322
New +$24.6K ﹤0.01% 404

Other funds holding RMD

Guardian Life Insurance's RMD Position: Q1 2020 in Review

Guardian Life Insurance sold out of ResMed (RMD) in Q1 2020, closing a stake of 420 shares — an estimated $65K sold.

Guardian Life Insurance first reported a position in RMD in Q3 2017 and held it in 10 quarters. The position peaked at $65K in Q4 2019. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

  • Guardian Life Insurance reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 420 ResMed shares in Q1 2020, an estimated $65K.
  • Guardian Life Insurance first reported a position in ResMed in Q3 2017 and held it in 10 quarters.
  • Guardian Life Insurance's ResMed position peaked at $65K in Q4 2019.
  • 584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.